Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.11 | - |
NAV | ₹16.61 | - |
Fund Started | 14 Sep 2023 | - |
Fund Size | ₹1983.91 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 30 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.11
-
NAV
₹16.61
-
Fund Started
14 Sep 2023
-
Fund Size
₹1983.91 Cr
-
Exit Load
Exit load of 1%, if redeemed within 30 days.
-
1 Year | 2.29% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
2.29%
-
3 Year
-
-
5 Year
-
-
Equity | 97.80% | - |
Cash | 2.20% | - |
Equity
97.80%
-
Cash
2.20%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.79% |
Divi's Laboratories Ltd. | 8.35% |
Glenmark Pharmaceuticals Ltd. | 6.45% |
Lupin Ltd. | 6.04% |
Alkem Laboratories Ltd. | 5.78% |
Max Healthcare Institute Ltd. | 5.74% |
Ipca Laboratories Ltd. | 4.56% |
Anthem Biosciences Ltd. | 4.05% |
Torrent Pharmaceuticals Ltd. | 3.89% |
Aster DM Healthcare Ltd. | 3.34% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. | - |
Launch Date | 14 Sep 2023 | - |
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
-
Launch Date
14 Sep 2023
-